Guerbet S. A. focuses on pioneering and distributing contrast media, advanced delivery systems, medical devices, and associated technological solutions. Their product lineup features several iodinated contrast agents, including Optiray and Xenetix, which are non-ionic monomeric compounds, alongside Telebrix Gastro, a meglumine ioxitalamate solution, and Conray, an iothalamate meglumine injection.